Specific drug delivery to the kidney

Area of Science:

• Nephrology
• Pharmacology
• Drug Delivery Systems

Background:

• Proximal tubular cells are key targets for renal drug delivery due to their role in kidney diseases.
• Existing drug delivery methods face challenges in achieving renal selectivity and efficacy.
• Two primary strategies for proximal tubular cell targeting include prodrugs and low-molecular-weight proteins (LMWPs).

Purpose of the Study:

• To review and analyze drug delivery strategies specifically targeting proximal tubular cells in the kidney.
• To evaluate the effectiveness and selectivity of prodrug and LMWP approaches for renal drug delivery.

Main Methods:

• Review of existing research on renal drug delivery to proximal tubular cells.
• Analysis of amino-acid prodrugs requiring kidney-selective enzyme activation.
• Examination of the low-molecular-weight protein (LMWP) approach involving drug attachment to filtered proteins.

Main Results:

• Amino-acid prodrugs exhibit variable renal selectivity due to factors like rapid drug removal or off-target cleavage.
• The LMWP approach demonstrates potential for higher renal selectivity and versatile drug attachment.
• Studies with captopril-lysozyme and naproxen-lysozyme confirm targeted delivery enhances renal selectivity and pharmacological activity.

Conclusions:

• The LMWP approach offers a promising strategy for targeted renal drug delivery to proximal tubular cells.
• Targeted delivery via LMWPs can improve drug efficacy and reduce side effects by concentrating therapeutic action within the kidney.
• Further research is needed to fully establish the clinical value of LMWP-based renal drug delivery systems.